Advanced metastatic midgut neuroendocrine tumors: New drug in development shows improved progression-free survival for patients

Posted by on January 12, 2017 3:08 pm
Tags:
Categories: health

A new therapy in development for the treatment of midgut neuroendocrine tumors, a rare type of cancer that occurs in the small intestine and colon, shows improved progression-free survival and response rates for patients with advanced disease.

Leave a Reply

Your email address will not be published.